ENXTPA:SANPharmaceuticals
Sanofi (ENXTPA:SAN) One Off €3.4b Charge Tests Bullish Earnings Narratives
Sanofi (ENXTPA:SAN) has wrapped up FY 2025 with fourth quarter revenue of €12.2b and a basic EPS loss of €0.67, alongside trailing 12 month revenue of €46.7b and EPS of €4.05 that still reflect the impact of a large one off €3.4b charge. Over recent periods, revenue has moved between €10.6b and €14.2b a quarter, while basic EPS has ranged from €1.01 to €2.32 in the first three quarters of 2025 before this latest loss. This sets a mixed backdrop for the trailing 10.6% net margin versus 12.4% a...